These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17223021)

  • 1. The preparation of pellets containing a surfactant or a mixture of mono- and di-gylcerides by extrusion/spheronization.
    Newton JM; Pinto MR; Podczeck F
    Eur J Pharm Sci; 2007 Mar; 30(3-4):333-42. PubMed ID: 17223021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preparation of pellets containing non-ionic surfactants by extrusion/spheronization.
    Podczeck F; Alessi P; Newton JM
    Int J Pharm; 2008 Sep; 361(1-2):33-40. PubMed ID: 18571347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M; Newton M; Booth S; Clarke A
    Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization.
    Boutell S; Newton JM; Bloor JR; Hayes G
    Int J Pharm; 2002 May; 238(1-2):61-76. PubMed ID: 11996811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of non-ionic surfactants on the rheological properties of drug/microcrystalline cellulose/water mixtures and their use in the preparation and drug release performance of pellets prepared by extrusion/spheronization.
    Podczeck F; Maghetti A; Newton JM
    Eur J Pharm Sci; 2009 Jun; 37(3-4):334-40. PubMed ID: 19491024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture.
    Newton M; Petersson J; Podczeck F; Clarke A; Booth S
    J Pharm Sci; 2001 Aug; 90(8):987-95. PubMed ID: 11536202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
    J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption.
    Iosio T; Voinovich D; Grassi M; Pinto JF; Perissutti B; Zacchigna M; Quintavalle U; Serdoz F
    Eur J Pharm Biopharm; 2008 Jun; 69(2):686-97. PubMed ID: 18191390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY; Yap HN; Chaw CS
    Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of a self-emulsifying pellet formulation.
    Abdalla A; Mäder K
    Eur J Pharm Biopharm; 2007 May; 66(2):220-6. PubMed ID: 17196807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of extrusion aids for successful production of Kollidon
    Loka NC; Saripella KK; Pinto CA; Neau SH
    Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
    Liew CV; Gu L; Soh JL; Heng PW
    Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P; Steffens KJ; Kleinebudde P
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-emulsifying Pellets Prepared by Extrusion/Spheronization: In vitro/In vivo Evaluation.
    Rahman MA; Mujahid M; Hussain A
    Recent Pat Drug Deliv Formul; 2016; 10(3):245-252. PubMed ID: 27774911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of model drugs on the preparation of pellets by extrusion/spheronization: II. Spheronization parameters.
    Tomer G; Podczeck F; Newton JM
    Int J Pharm; 2002 Jan; 231(1):107-19. PubMed ID: 11719019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization.
    Sousa JJ; Sousa A; Podczeck F; Newton JM
    Int J Pharm; 2002 Jan; 232(1-2):91-106. PubMed ID: 11790493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.
    Thommes M; Kleinebudde P
    AAPS PharmSciTech; 2007 Nov; 8(4):E95. PubMed ID: 18181555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.